JPS60258126A - Production of polymerized hemoglobin - Google Patents

Production of polymerized hemoglobin

Info

Publication number
JPS60258126A
JPS60258126A JP11352584A JP11352584A JPS60258126A JP S60258126 A JPS60258126 A JP S60258126A JP 11352584 A JP11352584 A JP 11352584A JP 11352584 A JP11352584 A JP 11352584A JP S60258126 A JPS60258126 A JP S60258126A
Authority
JP
Grant status
Application
Patent type
Prior art keywords
erythrocytes
blood
hemoglobin
resultant
glutaraldehyde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11352584A
Inventor
Teruo Tomota
Katsuro Yagawa
Kiyoo Yajima
Original Assignee
Teruo Tomota
Katsuro Yagawa
Kiyoo Yajima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Abstract

PURPOSE: To obtain relatively easily the titled hemoglobin capable of being an artificial blood capable of staying in blood for a long period without side effect even by blood transfusion, by adding and polymerizing glutaraldehyde to hemoglobin obtained by subjecting erythrocytes to the hypotonic treatment.
CONSTITUTION: An ACD or CPD preserved blood is centrifuged to separate blood plasma, granulocytes and erythrocytes. 0.9% NaCl solution in a volume of ≥5 times that of the resultant human erthrocytes is added thereto, and further centrifuged to take out the erythrocytes. The human erythrocytes after washing are hemolyzed with a 10mM phosphoric acid buffer solution in a volume of 5 times that of the erythrocytes for hypotonic treatment, and further centrifuged at an ultrahigh speed to separate and remove the erythrocytic membrane component. Glutaraldehyde is then added to the resultant hemoglobin which is a hemolyzed erythrocytic solution, and the resultant mixture is then allowed to stand at room temperature for 1hr. The resultant solution is then passed through a column to separate and remove the liberated glutaraldehyde. Thus, the aimed polymerized hemoglobin having high affinity for oxygen is obtained.
COPYRIGHT: (C)1985,JPO&Japio
JP11352584A 1984-06-02 1984-06-02 Production of polymerized hemoglobin Pending JPS60258126A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11352584A JPS60258126A (en) 1984-06-02 1984-06-02 Production of polymerized hemoglobin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11352584A JPS60258126A (en) 1984-06-02 1984-06-02 Production of polymerized hemoglobin

Publications (1)

Publication Number Publication Date
JPS60258126A true true JPS60258126A (en) 1985-12-20

Family

ID=14614548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11352584A Pending JPS60258126A (en) 1984-06-02 1984-06-02 Production of polymerized hemoglobin

Country Status (1)

Country Link
JP (1) JPS60258126A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63297330A (en) * 1987-05-05 1988-12-05 Chiyan Shia Jien Pasteurizable and freeze driable hemoglobin-base substitute blood
JPH05502240A (en) * 1990-08-17 1993-04-22

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51109983A (en) * 1975-02-27 1976-09-29 Alza Corp

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51109983A (en) * 1975-02-27 1976-09-29 Alza Corp

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63297330A (en) * 1987-05-05 1988-12-05 Chiyan Shia Jien Pasteurizable and freeze driable hemoglobin-base substitute blood
JPH0532372B2 (en) * 1987-05-05 1993-05-14 Shia Jennchan
JPH05502240A (en) * 1990-08-17 1993-04-22

Similar Documents

Publication Publication Date Title
Wakitani et al. Repair of rabbit articular surfaces with allograft chondrocytes embedded in collagen gel
Warrell et al. Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria
Silver et al. Arachidonic acid causes sudden death in rabbits
USRE32874E (en) Plasma-free medium for platelet storage
US5246715A (en) Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same
EP0317053A2 (en) Trigramin- a platelet aggregation inhibiting polypeptide
Agostino et al. Effect of heparin on circulating Walker carcinosarcoma 256 cells
US4203891A (en) Method of collecting anti-hemophilic factor VIII from blood and blood plasma using heparin or sodium heparin
Hillyer et al. Increase in circulating colony‐forming units‐granulocyte‐macrophage during large‐volume leukapheresis: evaluation of a new cell separator
Moyle et al. Purification of the isocitric enzyme (triphosphopyridine nucleotide-linked isocitric dehydrogenase–oxalosuccinic carboxylase
Carter et al. Control of gamete formation (exflagellation) in malaria parasites
Rao et al. Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions
EP0239859A2 (en) Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
US4359463A (en) Stabilization of Factor VIII activity in whole blood or blood plasma
White et al. Synergistic toxicity of endotoxin and hemoglobin
Day The release of substances like acetylcholine and adrenaline by the isolated rabbit heart
US4115551A (en) Compounds of the plasminogen type and method for obtaining such compounds from placental pulps
Mück‐Šeler et al. Platelet serotonin (5‐HT) and 5‐HT releasing factor in plasma of migrainous patients
Eldor et al. Heparin and dextran sulfate antagonize PGI2 inhibition of platelet aggregation
Koster et al. Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin
Miller et al. Deep vascular schizogony of Plasmodium knowlesi in Macaca mulatta
White et al. The effects of trifluoperazine. An inhibitor of calmodulin, on platelet function
Lochhead et al. The enzymic formation of haem by human and rat tissues
Gattegno et al. Changes in carbohydrate content of surface membranes of human erythrocytes during ageing
Valeri Circulation and hemostatic effectiveness of platelets stored at 4 C or 22 C: studies in aspirin‐treated normal volunteers